-
3-Bromopyruvate Overcomes Cetuximab Resistance
2026-08-24
This 2023 Cancer Gene Therapy study shows that combining 3-bromopyruvate with cetuximab can suppress colorectal cancer models that are intrinsically or adaptively resistant to cetuximab. The work links FOXO3a restoration to AMPKα–Beclin1 and PUMA signaling, providing a mechanistic explanation for coordinated autophagy, ferroptosis, and apoptosis.
-
Betacoronaviruses Rewire the Integrated Stress Response
2026-08-24
This preprint shows that MERS-CoV, HCoV-OC43, and SARS-CoV-2 engage the PERK–eIF2α branch of the integrated stress response differently in lung-derived cell lines. The results identify virus-specific dependence on eIF2α dephosphorylation and suggest that host-directed antiviral strategies must account for coronavirus-specific translational control.
-
Merimepodib: Mapping IMPDH Dependence in Assays
2026-08-23
Merimepodib (VX-497) is a selective IMPDH inhibitor whose effects can reveal how cells and viruses depend on guanine nucleotide biosynthesis. This article translates recent PEDV findings into a mechanistic framework for designing interpretable antiviral, lymphocyte, and proliferation assays.
-
CTP Solution for p21 mRNA-LNP Workflows
2026-08-22
CTP Solution (100 mM) provides a defined Cytidine-5'-triphosphate input for in vitro transcription workflows that support mRNA-LNP research. This article connects reagent control with the localized p21 mRNA delivery strategy reported in bladder cancer while separating published findings from practical optimization recommendations.
-
CRTC–CREB Senses Proteotoxic Stress in Drosophila
2026-08-21
The reference study identifies CRTC–CREB as a stress-responsive transcriptional axis that is activated by proteasome inhibition through ROS and JNK signaling. In Drosophila models of Huntington’s disease and aging, increasing CRTC–CREB activity improved proteostasis and reduced protein aggregation, suggesting a conserved framework for studying adaptive responses to proteotoxic stress.
-
Bortezomib (PS-341) for ERAD and Apoptosis
2026-08-20
Use Bortezomib (PS-341) as a reversible 20S proteasome perturbation tool to connect ERAD substrate turnover with apoptosis and proteostasis phenotypes. This workflow combines concentration-controlled cell assays, degron-reporter validation, and troubleshooting controls for cancer and ER quality-control models.
-
AICAR Workflows for AMPK Metabolic Research
2026-08-20
A practical guide to using AICAR as a cell-permeable AMPK probe in energy metabolism, inflammation, and hepatic fibrosis assays. Learn how to connect pathway activation with lipid-droplet imaging, cytokine profiling, and reproducible troubleshooting.
-
Drug Response Metrics in Cancer In Vitro
2026-08-19
Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell killing are related but non-equivalent dimensions of anticancer drug response. This framework helps researchers design assays that separate cytostatic effects from lethality, interpret time-dependent responses, and avoid treating a single viability measurement as a direct apoptosis readout.
-
Firefly Luciferase mRNA: Delivery & Assay Workflow
2026-08-19
Build sensitive delivery, translation, viability, and imaging assays with a capped, 5-moUTP-modified firefly reporter. This workflow connects transcript handling and lipoplex formulation to practical controls, readout timing, and troubleshooting for reproducible expression data.
-
Solanesol: Practical Workflow and QC Guide
2026-08-18
Solanesol is a hydrophobic polyisoprenoid alcohol for controlled biochemical workflows involving membrane-related processes and enzyme or cell-based assay development. It should be prepared in DMSO rather than water or ethanol, with fresh-solution handling, solvent-matched controls, and no use in diagnostic, clinical, or medical workflows.
-
Engage & Evasion: Improving EV Delivery in Ischemia
2026-08-18
Liu et al. developed a sequential “Engage & Evasion” strategy in which CD47-low extracellular vesicles first interact with and occupy the mononuclear phagocyte system, followed by administration of CD47-high vesicles designed to resist phagocytic uptake. The approach reduced liver and spleen entrapment, increased circulating vesicle levels, and improved accumulation in non-MPS organs, providing a distribution-focused framework for ischemic disease therapy.
-
IEM-1925 Against Soman-Induced Neurotoxicity
2026-08-17
A 2026 NeuroToxicology study tested IEM-1925 in a rat model of soman-induced status epilepticus and found combined antiseizure, neuroprotective, and cognitive benefits. Its dual AMPA/NMDA receptor strategy reduced prolonged seizure activity, hippocampal injury, and behavioral deficits more consistently than diazepam, highlighting glutamate-driven excitotoxicity as a therapeutic target.
-
CAPE NF-κB Assays in Neuroinflammation Research
2026-08-17
Caffeic Acid Phenethyl Ester (CAPE) provides a temporally controllable way to perturb NF-κB signaling in cellular and disease-model workflows. This article translates CAPE’s established inflammatory, angiogenic, and invasion-related activities into practical assay designs for testing the Stat3–NF-κB cooperation reported in a zebrafish model of Fyn-driven neurodegeneration.
-
5-Azacytidine and Bortezomib in Myeloma Cells
2026-08-16
This reference study showed that 5-azacytidine kills therapy-sensitive, therapy-resistant, and patient-derived multiple myeloma cells through DNA double-strand break responses involving ATR, followed by both caspase-dependent and caspase-independent apoptosis. Its combination data provided a preclinical rationale for pairing DNA methyltransferase inhibition with doxorubicin or Bortezomib, while also highlighting the importance of testing drug activity in microenvironmental and resistant-cell models.
-
Co-IP as a Translational Lens on Stroke Mechanisms
2026-08-15
Co-immunoprecipitation can convert a plausible signaling model into experimentally testable evidence. Using the RNF8/DAPK1 findings in ischemic stroke as a case study, this article explains how magnetic bead workflows can strengthen protein-complex isolation, improve reproducibility, and support translational decision-making.